Condition: Pseudoxanthoma Elasticum · Sponsor: UMC Utrecht
The goal of this randomized clinical trial is to assess the effect of etidronate on ectopic calcification in relatively young patients with Pseudoxanthoma elasticum. The main question it aims to answer are: What is the difference in the arterial calcification scores in the legs and the carotid syphon measured on low-dose CT scan after 24 months of treatment compared to baseline between etidronate and placebo. Participants will be asked to do take etidronate or placebo for 24 months.
This description comes directly from the study's public registry record.
Wilko Spiering, MD, PhD · + 88 755 5555 · w.spiering@umcutrecht.nl
Iris Harmsen, MD · + 88 755 5555 · i.m.harmsen@umcutrecht.nl
Always discuss trial participation with your own doctor first.
| University Medical Center Utrecht | Utrecht, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05832580